Market Value1,242,296,000
Total Holdings42
File Date2022-05-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
US31816QAD34 / FireEye, Inc. Bond
US88339PAB76 / RealReal, Inc. (The), Conv.
US868459AD01 / Supernus Pharmaceuticals Inc Bond
US78781PAB13 / CONV. NOTE
US282914AB63 / CONV. NOTE
US682189AP09 / On Semiconductor Corp Bond
US922417AF70 / Veeco Instruments, Inc.
US64829BAB62 / New Relic Inc Bond
US67059NAB47 / Nutanix, Inc. Bond
US462222AB68 / Ionis Pharmaceuticals Inc
US958102AP07 / Western Digital Corp Bond
US02156BAD55 / CONV. NOTE
US05351XAB73 / Avaya Hldgs Corp Bond
US207410AF81 / CONV. NOTE
US22266LAC00 / CONV. NOTE
US09239BAD10 / Blackline, Inc., Conv.
US22266LAF31 / CONV. NOTE
US253393AD47 / CONV. NOTE
US256163AD89 / CONVERTIBLE ZERO
US29404KAB26 / Envestnet Inc Bond
US29978AAE47 / CONVERTIBLE ZERO
US29978AAC80 / Everbridge Inc
US31188VAB62 / FASTLY INC CONV 0% 03/15/2026
HESKA CORP / NOTE 3.750% 9/1 (42805EAB4)
US48576UAA43 / Karyopharm Therapeutics Inc
US48242WAB28 / KBR INC CONV 2.5% 11/01/2023
US64049MAA80 / NeoGenomics Inc
US64049MAB63 / NeoGenomics Inc
US670704AL95 / NuVasive Inc
US682143AE23 / Omeros Corp., Series 2004-HYB1
US607525AB88 / Model N, Inc.
US74736LAF67 / Q2 Holdings Inc
US925550AB17 / Viavi Solutions Inc Bond
US90184LAN29 / CONVERTIBLE ZERO
US98139AAB17 / Workiva Inc
US69366JAB70 / PTC Therapeutics, Inc. Bond
US98936JAD37 / CONV. NOTE
US705573AB99 / CONV. NOTE
WIX / Wix.com Ltd.
US011642AB16 / CONVERTIBLE ZERO
NVMI / Nova Ltd.
US45765UAB98 / INSIGHT ENTERPRISES INC CONV 0.75% 02/15/2025